Home » Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial

Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial

by Fernandes, Ricardo, Jabbarizadeh, Behnam, Rajeh, Adnan, Hong, Megan M Y, Baines, Kelly J., Ernst, Scott, Winquist, Eric, Ali, Anorin Shadi, Penny, Susanne, Figueredo, Rene, Parvathy, Seema Nair, Lenehan, John G., Pinto, Devanand M., Silverman, Michael S. & Maleki Vareki, Saman | Jan 28, 2026 | Articles | 0 Comments